Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D
- 1 August 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (12) , 1629-1636
- https://doi.org/10.1097/01.aids.0000131392.68597.34
Abstract
To determine whether different HIV-1 genotypes present in a single cohort, in Dar es Salaam, Tanzania, showed differences in timing for transmission from mothers to their infants. We determined the maternal viral load, transmission time, and the HIV-1 envelope (env) subtype of 253 HIV-1-infected infants enrolled in a randomized double-blind placebo-controlled trial to examine the efficacy of vitamins in decreasing mother-to-child transmission in Tanzania. Classification of HIV-1 positivity in utero was based on PCR results at birth. Infants were classified as intrapartum infected if they scored negative for the sample collected at birth and positive for the sample collected at 6 weeks of age. We found significant differences in the distribution of transmission time according to subtype. A higher proportion of HIV-1 with subtype C env (C-env) was transmitted in utero than HIV-1 with subtype A env (A-env), subtype D env (D-env), or both combined. The identification of patterns of mother-to-child transmission times among HIV-1 genotypes may be useful in the selection of drug regimens for chemoprophylaxis. Based on our results, the efficacy of regimens administered only at labor may not protect as large a fraction of infants born in geographical regions with subtype C-env epidemics as compared to epidemics in regions where subtypes A-env and D-env predominate in the population.Keywords
This publication has 31 references indexed in Scilit:
- Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortalityAIDS, 2002
- HIV-1 LTR Subtype and Perinatal TransmissionVirology, 2001
- Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian womenAIDS, 2001
- Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?The Lancet, 2000
- Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapyAIDS, 2000
- Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 regionAIDS, 1999
- Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease ProgressionThe Journal of Infectious Diseases, 1999
- Sequence Note: Epidemic Expansion of HIV Type 1 Subtype C and Recombinant Genotypes in TanzaniaAIDS Research and Human Retroviruses, 1998
- Maternal Immunologic and Virologic Risk Factors for Infant Human Immunodeficiency Virus Type 1 Infection: Findings from the Women and Infants Transmission StudyThe Journal of Infectious Diseases, 1997
- A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau Per-AkeAIDS, 1993